Curcumin Phytosome

Curcumin Phytosome

Jarrow Formulas4.8 (10,157 ratings)
Format:Capsule Quantity: 60 Veggie Cap(s) · 60 servings
Goals

Product analysis

61 out of 100

Curcumin Phytosome may support joint comfort, although the benefit depends on the particular preparation and repeated use. The label does not establish a match to the specific extracts behind those findings.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality40

Curcumin and its plant source are identified, but the preparation quality remains uncertain. The name alone does not establish equivalent absorption to a particular studied extract.

Ingredient Transparency80

The amount and ingredient description are disclosed, making basic serving comparisons possible. The proportions within the preparation are missing, leaving its composition less clear.

Value For Money50

The labeled serving offers moderate value. That price comparison does not establish equivalent benefit between curcumin preparations.

Customer Satisfaction92

Customer feedback is very positive across a very large review pool. The volume gives a broad picture of satisfaction, without proving effectiveness or safety.

Product Focus63

Joint comfort is a plausible use, with limited support that depends on the preparation. The broader aging and liver claims are less direct and do not establish preserved function or routine toxin clearance.

Format
Capsule
Container
60 Veggie Cap(s)
Per serving
$0.38
Customer rating
4.8 · 10,157 ratings
Report analysis

Goals

Inflammation
Impact
Moderate effect
B- Ingredient FitF PathwaysF EvidenceB Formulation Logic
Curcumin · 500 mg

The 500 mg curcumin serving relates mainly to inflammatory signalling. Some identified curcumin preparations have supported joint comfort, but those findings depend on the preparation and repeated use. The saved assessment gives this serving a partial contribution and records a missing absorption partner.

How this product is rated for Inflammation

Ingredient fit75

The relevant ingredient is the main focus of the formula. The relevant amounts provide a partial match to the saved dose comparisons.
Goal fit
The relevant ingredient is the main focus of the formula.
Dose adequacy
The relevant amounts provide a partial match to the saved dose comparisons.

Pathways9

The strongest saved connection is inflammatory gene signalling (nf-kb), with limited coverage. None of the reviewed routes reaches the saved level for broad coverage.
Depth
The strongest saved connection is inflammatory gene signalling (nf-kb), with limited coverage.
Breadth
None of the reviewed routes reaches the saved level for broad coverage.

Evidence32

Curcumin provides the strongest saved evidence at the assessed amount; its relevance remains dependent on the studied context. The relevant preparation was not matched to the reviewed human evidence.
Evidence strength
Curcumin provides the strongest saved evidence at the assessed amount; its relevance remains dependent on the studied context.
Studied preparation
The relevant preparation was not matched to the reviewed human evidence.

Formulation logic76

Curcumin is missing the absorption partner recorded in the saved assessment. No ingredient conflicts were recorded in the supplied assessment. 1 of 1 assessed ingredients reach the saved amount threshold.
Partner coverage
Curcumin is missing the absorption partner recorded in the saved assessment.
Conflicts
No ingredient conflicts were recorded in the supplied assessment.
Effective doses
1 of 1 assessed ingredients reach the saved amount threshold.
Study evidence
Curcumin Supportive 68 studies
Joint Health
Impact
Moderate effect
B- Ingredient FitF PathwaysF EvidenceA+ Formulation Logic
Curcumin · 500 mg

Curcumin at 500 mg relates to inflammatory processes and may support joint comfort. The supplied evidence is preparation-specific and limited, so the declared amount and curcuminoid description do not establish equivalence to the particular extract behind the reviewed trial.

How this product is rated for Joint Health

Ingredient fit75

The relevant botanical provides a clear focus on the reviewed joint functions. Ingredient amounts provide a partial match to the saved exposure comparisons.
Goal fit
The relevant botanical provides a clear focus on the reviewed joint functions.
Dose adequacy
Ingredient amounts provide a partial match to the saved exposure comparisons.

Pathways9

The main mechanism in the saved assessment is inflammation control. None of the three target mechanisms reaches the saved coverage threshold.
Depth
The main mechanism in the saved assessment is inflammation control.
Breadth
None of the three target mechanisms reaches the saved coverage threshold.

Evidence27

Curcumin leads the saved evidence finding; normal function or an exposure match does not guarantee symptom improvement. The counted botanical lacks a confirmed match to the relevant studied preparation.
Evidence strength
Curcumin leads the saved evidence finding; normal function or an exposure match does not guarantee symptom improvement.
Studied preparation
The counted botanical lacks a confirmed match to the relevant studied preparation.

Formulation logic100

The counted ingredients can contribute independently or have their required partner. No configured ingredient conflict was found in the supplied assessment. 1 of 1 counted ingredients reach the saved minimum amount criterion.
Partner coverage
The counted ingredients can contribute independently or have their required partner.
Conflicts
No configured ingredient conflict was found in the supplied assessment.
Effective doses
1 of 1 counted ingredients reach the saved minimum amount criterion.
Study evidence
Curcumin Supportive 62 studies
Longevity
Impact
High effect
B- Ingredient FitD- PathwaysA EvidenceA+ Formulation Logic
Curcumin · 500 mg

Curcumin has a connection to inflammation-related activity, but that mechanism does not establish preservation of aging-related function. The supplied memory trial used Theracurmin and included participants with mild cognitive impairment; benefit in the healthy subgroup was not established. The product's curcuminoid declaration does not establish equivalence to that preparation, and its 500 mg serving cannot be treated as a validated anti-aging dose.

How this product is rated for Longevity

Ingredient fit75

Curcumin is the sole goal-related active, with a partial amount contribution.
Goal fit
Curcumin is the sole goal-related active, with a partial amount contribution.
Dose adequacy
The declared amount provides partial coverage of the saved amount reference, without establishing an effective anti-aging dose.

Pathways40

Inflammation-related activity is the only mapped area.
Depth
Inflammation-related activity is the strongest mapped area.
Breadth
Only inflammation-related activity is represented.

Evidence95

The saved preparation finding is favorable, but the supplied trial context limits expectations for healthy adults.
Evidence strength
The memory findings do not establish preservation of function in healthy adults.
Studied preparation
The saved preparation finding does not establish equivalence between this curcuminoid declaration and Theracurmin.

Formulation logic100

Curcumin meets the saved amount threshold without a missing partner requirement.
Partner coverage
The counted ingredients work independently or have their required partner; no extra combination benefit is established.
Conflicts
No conflict was identified among the evaluated ingredient combinations.
Effective doses
Curcumin meets the saved amount threshold without a missing partner requirement.
Study evidence
Curcumin Supportive 6 studies
Liver & Detox
Impact
High effect
B- Ingredient FitF PathwaysB+ EvidenceA+ Formulation Logic
Curcumin · 500 mg

Curcumin research concerns particular preparations and fatty-liver disease outcomes, rather than removal of unspecified toxins.

How this product is rated for Liver & Detox

Ingredient fit75

The recognized ingredients and their declared amounts shape the formula’s focus; routine toxin removal is not established.
Goal fit
The recognized ingredient gives this formula a focused composition for the comparison.
Dose adequacy
The declared amounts partly meet the saved amount comparison; that comparison does not establish a clinical detoxification dose.

Pathways19

The saved findings describe biochemical routes rather than demonstrated clearance of toxins. Their depth and breadth are distinguished below.
Depth
Detox-enzyme induction is the strongest saved route; this biochemical finding does not demonstrate toxin clearance.
Breadth
No configured route reached the coverage criterion.

Evidence81

The saved evidence findings recognize ingredients and preparations, while the human research remains limited to nutritional or specific clinical settings.
Evidence strength
Curcumin leads the saved evidence finding; the supplied research does not establish generalized detoxification in unselected adults.
Studied preparation
The saved comparison recognizes the included preparation, but disease-specific studies cannot establish a routine detoxification benefit.

Formulation logic100

No required partner is missing, and none of the specified conflicts was triggered.
Partner coverage
No required partner is missing for the recognized ingredients; this does not establish synergistic toxin clearance.
Conflicts
None of the specified conflicts was triggered in the supplied findings.
Effective doses
All recognized ingredients meet the minimum amount criterion; this does not establish an effective clinical detoxification dose.
Study evidence
Curcumin Supportive 30 studies

Ingredients

IngredientAmount per servingScore
Meriva Curcumin Phytosome Phosphatidylcholine Complex (Curcuma longa, Curcuminoids)
500 mg 90
Gluten Free Adults 18–50 Vegan Dairy Free Vegetarian
Report overview
A+ Composition And Label DisclosureA+ Composition And Label DisclosureD+ Commercial Price And Usability
Each serving has 500 mg of curcumin phytosome with a stated 18% curcuminoid yield. That corresponds to 90 mg of curcuminoids, calculated from the stated yield rather than independently measured.
How this ingredient is rated

Composition and Label Disclosure100

A stated yield makes it possible to estimate the curcuminoid content of the phytosome preparation.
Curcuminoid Amount Disclosure
The 500 mg phytosome preparation has a stated 18% curcuminoid yield, corresponding to 90 mg.

Composition and Label Disclosure100

The saved facts include the preparation amount, yield and a testing-seal claim; these are label disclosures, not independently verified measurements.
Preparation and Marker Disclosure
The preparation amount and yield are recorded along with a testing-seal claim; the claim has not been independently verified.

Commercial Price and Usability50

The whole product costs about $0.37 per labeled serving.
Commercial Price per Labeled Serving
The whole product costs about $0.37 per labeled serving.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Effect of curcumin on inflammatory markers and disease activity in patients with rheumatoid arthritis: A meta-analysis.
    Zhang F; Niu B · Medicine · 2025
    Meta-analysis7 studies pooledInflammation forCurcumin
  2. Effect of curcumin on C-reactive protein as a biomarker of systemic inflammation: An updated meta-analysis of randomized controlled trials.
    Gorabi AM; Abbasifard M; Imani D; Aslani S; Razi B; Alizadeh S; Bagheri-Hosseinabadi Z; Sathyapalan T; Sahebkar A · Phytotherapy research : PTR · 2022
    Meta-analysis32 studies pooledInflammation forCurcumin
  3. Effect of curcumin on circulating interleukin-6 concentrations: A systematic review and meta-analysis of randomized controlled trials.
    Derosa G; Maffioli P; Simental-Mendía LE; Bo S; Sahebkar A · Pharmacological research · 2018
    Meta-analysis9 studies pooledInflammation forCurcumin
  4. Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial.
    Jazayeri-Tehrani SA; Rezayat SM; Mansouri S; Qorbani M; Alavian SM; Daneshi-Maskooni M; Hosseinzadeh-Attar MJ · Nutrition & metabolism · 2024
    Randomized trial84 participantsInflammation Liver & Detox forCurcumin
  5. Is Curcumin Intake Really Effective for Chronic Inflammatory Metabolic Disease? A Review of Meta-Analyses of Randomized Controlled Trials.
    Lee YM; Kim Y · Nutrients · 2024
    Systematic review54 studies pooledInflammation forCurcumin
  6. Efficacy and safety of curcumin therapy for knee osteoarthritis: A Bayesian network meta-analysis.
    Zhao J; Liang G; Zhou G; Hong K; Yang W; Liu J; Zeng L · Journal of ethnopharmacology · 2024
    Meta-analysis2,175 participants23 studies pooledJoint Health forCurcumin
  7. Efficacy and Safety of Curcumin and Curcuma longa Extract in the Treatment of Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trial.
    Zeng L; Yang T; Yang K; Yu G; Li J; Xiang W; Chen H · Frontiers in immunology · 2022
    Meta-analysis2,396 participants29 studies pooledJoint Health forCurcumin
  8. The efficacy of curcumin in relieving osteoarthritis: A meta-analysis of meta-analyses.
    Bideshki MV; Jourabchi-Ghadim N; Radkhah N; Behzadi M; Asemani S; Jamilian P; Zarezadeh M · Phytotherapy research : PTR · 2024
    Meta-analysis11 studies pooledJoint Health forCurcumin
  9. The efficacy of high- and low-dose curcumin in knee osteoarthritis: A systematic review and meta-analysis.
    Hsiao AF; Lien YC; Tzeng IS; Liu CT; Chou SH; Horng YS · Complementary therapies in medicine · 2021
    Meta-analysis1,258 participants11 studies pooledJoint Health forCurcumin
  10. The efficacy and safety of Curcuma longa extract and curcumin supplements on osteoarthritis: a systematic review and meta-analysis.
    Zeng L; Yu G; Hao W; Yang K; Chen H · Bioscience reports · 2022
    Meta-analysis1,621 participants15 studies pooledJoint Health forCurcumin
  11. Curcumin supplementation effect on liver enzymes in patients with nonalcoholic fatty liver disease: a GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials.
    Vajdi M; Hassanizadeh S; Hassanizadeh R; Bagherniya M · Nutrition reviews · 2024
    Meta-analysis905 participants15 studies pooledLiver & Detox forCurcumin
  12. Therapeutic effects of curcumin supplementation on liver enzymes of nonalcoholic fatty liver disease patients: A systematic review and meta-analysis of randomized clinical trials.
    Ebrahimzadeh A; Ebrahimzadeh A; Fooladshekan S; Mohseni S; Mohtashamian A; Babajafari S; Sohrabi Z · Food science & nutrition · 2025
    Meta-analysis14 studies pooledLiver & Detox forCurcumin
  13. Curcumin Attenuates Liver Steatosis via Antioxidant and Anti-Inflammatory Pathways in Obese Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial.
    Yaikwawong M; Kamdee K; Chuengsamarn S · International journal of molecular sciences · 2025
    Randomized trial227 participantsLiver & Detox forCurcumin
  14. A Novel Curcumin-Galactomannoside Complex Delivery System Improves Hepatic Function Markers in Chronic Alcoholics: A Double-Blinded, randomized, Placebo-Controlled Study.
    T Krishnareddy N; Thomas JV; Nair SS; N Mulakal J; Maliakel BP; Krishnakumar IM · BioMed research international · 2019
    Randomized trial48 participantsLiver & Detox forCurcumin
  15. Further Evidence of Benefits to Mood and Working Memory from Lipidated Curcumin in Healthy Older People: A 12-Week, Double-Blind, Placebo-Controlled, Partial Replication Study.
    Cox KHM; White DJ; Pipingas A; Poorun K; Scholey A · Nutrients · 2021
    Randomized trial80 participantsLongevity forCurcumin
  16. Curcumin ingestion and exercise training improve vascular endothelial function in postmenopausal women.
    Akazawa N; Choi Y; Miyaki A; Tanabe Y; Sugawara J; Ajisaka R; Maeda S · Nutrition research (New York, N.Y.) · 2013
    Clinical trial32 participantsLongevity forCurcumin
  17. A novel phospholipid delivery system of curcumin (Meriva®) preserves muscular mass in healthy aging subjects.
    Franceschi F; Feregalli B; Togni S; Cornelli U; Giacomelli L; Eggenhoffner R; Belcaro G · European review for medical and pharmacological sciences · 2016
    Non-randomized trial86 participantsLongevity forCurcumin
  18. Curcumin: A Golden Approach to Healthy Aging: A Systematic Review of the Evidence.
    Nunes YC; Mendes NM; Pereira de Lima E; Chehadi AC; Lamas CB; Haber JFS; Dos Santos Bueno M; Araújo AC; Catharin VCS; Detregiachi CRP; Laurindo LF; Tanaka M; Barbalho SM; Marin MJS · Nutrients · 2024
    Systematic review15 studies pooledLongevity forCurcumin
  19. Curcumin and arterial function in health and disease: impact on oxidative stress and inflammation.
    Fleenor BS; Carlini NA; Campbell MS · Current opinion in clinical nutrition and metabolic care · 2020
    Narrative reviewLongevity forCurcumin